Also trades as: ICCM.TA (TLV) · $vol 0M
ICCM NASDAQ
IceCure Medical Ltd
1W: -9.2%
1M: -30.5%
3M: -65.9%
YTD: -91.7%
1Y: -94.7%
3Y: -91.3%
5Y: -99.5%
$1.57
-0.12 (-7.10%)
Weekly Expected Move ±7.5%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$3M
+2.7% ▲
5Y CAGR: -3.7%
Gross Profit
$1M
-23.6% ▼
5Y CAGR: -16.0%
Operating Income
-$15M
+3.8% ▲
Net Income
-$15M
+1.7% ▲
EPS (Diluted)
$-0.24
+20.0% ▲
EBITDA
-$15M
+3.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4M | $3M | $3M | $3M | $3M |
| YoY Growth | +1.3% | -25.4% | +4.7% | +1.9% | +2.7% |
| Cost of Revenue | $2M | $2M | $2M | $2M | $2M |
| Gross Profit | $2M | $1M | $1M | $1M | $1M |
| Gross Margin | 53.0% | 46.8% | 40.3% | 44.1% | 32.8% |
| R&D Expenses | $6M | $9M | $8M | $7M | $7M |
| SG&A Expenses | $6M | $9M | $9M | $10M | $9M |
| Operating Expenses | $12M | $18M | $17M | $17M | $16M |
| Operating Income | -$10M | -$17M | -$16M | -$16M | -$15M |
| Operating Margin | -235.0% | -542.6% | -482.4% | -476.9% | -446.7% |
| Interest Expense | $171K | $239K | $0 | $0 | $0 |
| Income Before Tax | -$10M | -$17M | -$15M | -$15M | -$15M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$10M | -$17M | -$15M | -$15M | -$15M |
| Net Margin | -243.3% | -558.1% | -453.8% | -465.5% | -445.6% |
| EPS (Diluted) | $-0.35 | $-0.47 | $-0.32 | $-0.30 | $-0.24 |
| EBITDA | -$10M | -$16M | -$15M | -$15M | -$15M |
| Shares Outstanding | 29M | 37M | 46M | 51M | 64M |